Immix Biopharma, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| AIGH CAPITAL MANAGEMENT LLC | 11/13/2024 | 1.12 M | $1.67 M | -20.12% | 3.82% |
| BLEICHROEDER LP | 11/13/2024 | 850,000 | $1.27 M | 0.00% | 2.89% |
| CABLE CAR CAPITAL LLC | 11/14/2024 | 796,100 | $1.19 M | 0.00% | 2.71% |
| VANGUARD GROUP INC | 11/13/2024 | 698,537 | $1.04 M | 16.71% | 2.37% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 150,082 | $223,651 | 5.60% | 0.51% |
| MORGAN STANLEY | 11/14/2024 | 84,313 | $125,626 | 44.23% | 0.29% |
| ROYAL BANK OF CANADA | 11/14/2024 | 84,000 | $125,000 | 100.00% | 0.29% |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | 11/08/2024 | 43,300 | $64,517 | 14.55% | 0.15% |
| STATE STREET CORP | 11/14/2024 | 42,960 | $64,010 | 0.00% | 0.15% |
| PRIVATE ADVISOR GROUP, LLC | 10/22/2024 | 34,325 | $51,145 | -47.33% | 0.12% |
| INVST, LLC | 11/19/2024 | 27,000 | $40,230 | 0.00% | 0.09% |
| COMMONWEALTH EQUITY SERVICES, LLC | 10/18/2024 | 26,080 | $39,000 | 0.00% | 0.09% |
| TRITONPOINT WEALTH, LLC | 10/28/2024 | 24,526 | $38,261 | 0.00% | 0.08% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 21,521 | $32,066 | -18.17% | 0.07% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 14,003 | $20,864 | 100.00% | 0.05% |
| COLONY GROUP, LLC | 11/14/2024 | 11,900 | $17,731 | 0.00% | 0.04% |
| OLD NATIONAL BANCORP /IN/ | 10/18/2024 | 10,000 | $14,900 | 0.00% | 0.03% |
| CITADEL ADVISORS LLC | 11/14/2024 | 8,900 | $13,261 | 100.00% | 0.03% |
| UBS GROUP AG | 11/14/2024 | 6,146 | $9,158 | 94.86% | 0.02% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2024 | 3,110 | $4,634 | -21.98% | 0.01% |
| STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 11/14/2024 | 1,492 | $2,223 | 0.00% | 0.01% |
| TORTOISE INVESTMENT MANAGEMENT, LLC | 11/13/2024 | 1,300 | $1,937 | 0.00% | 0.00% |
| CITADEL ADVISORS LLC | 11/14/2024 | 1,200 | $1,788 | 100.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 11/13/2024 | 950 | $1,416 | 0.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 11/13/2024 | 330 | $492 | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 115 | $171 | 0.00% | 0.00% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 0 | $0 | -100.00% | 0.00% |
| CORSAIR CAPITAL MANAGEMENT, L.P. | 11/13/2024 | 0 | $0 | -100.00% | 0.00% |
| SQUAREPOINT OPS LLC | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| FNY INVESTMENT ADVISERS, LLC | 10/18/2024 | 0 | $0 | -100.00% | 0.00% |
| XTX TOPCO LTD | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
Immix Biopharma, Inc.institutional Ownership - FAQ's
During the previous two years, 33 institutional investors and hedge funds held shares of Immix Biopharma, Inc.. The most heavily invested institutionals were:
AIGH Capital Management LLC: 1.12 M
Bleichroeder LP: 850,000
Cable Car Capital LLC: 796,100
VANGUARD GROUP INC: 698,537
GEODE CAPITAL MANAGEMENT, LLC: 150,082
MORGAN STANLEY: 84,313
13.92% of Immix Biopharma, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 4.51 M shares in the last 24 months. This purchase volume represents approximately $10.11 M in transactions.